Floatz logo

MARBLE DUST

Osteoporosis, Postmenopausal

Aristotle University Of ThessalonikiSmall moleculePhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Osteoporosis, Postmenopausal cohort.

Asset / SponsorPhaseRating
VITAMIN D
Aristotle University Of Thessaloniki
Phase 4BB
Arzoxifene
Eli Lilly and Company
Phase 3BB
Denosumab
Aristotle University Of Thessaloniki
Phase 4B
ALENDRONIC ACID
Aristotle University Of Thessaloniki
Phase 4B

Same molecule, other indications

MARBLE DUST is also rated in:

colorectal cancerDormant
BB
Indicative ·
71 / 100
View asset →
colon adenomaDormant
BB
Indicative ·
68 / 100
View asset →
Nonalcoholic Fatty LiverDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →